- Holland's Bear Advice: Buy the Survivors

- Analyst Picks: Three Resilient Retailers

- Ford Options Rev on Possible Volvo Deal
- BlackRock's Doll: Win With Last Week's Laggards

- Lucky 13? Bakers' Dozen Stock Picks

- Stock Picker: Time To Buy Value (Pt. 2)

- Stock Picker: Time To Buy Value (Pt. 1)

- Luxury Tech Stocks at Knock-Off Prices
- Options Action: Traders Bet on Potash
- Travel Stocks as a Value Play
- Holland's Bear Advice: Buy the Survivors
- Cramer's Outrage: Paulson & Bernanke
- Lightning Round: Genzyme, Goldman Sachs, U.S. Steel and More
- Lightning Round OT: Verizon, Kroger, Novartis and More
- Executive Decision: Foster Wheeler CEO Ray Milchovich
- Cavs Owner Doesn't Mind Buzz Over James
- Trading Obama's Stimulus Plan
- What Bailouts?
- Your First Move For Tuesday December 2nd
- Web Extra: Fast & Furious Trades For Tuesday
- Toyota to Cut Bonuses Amid Reports of Output Cuts
- China Eyes Consumer Boost, May Aim 8% 2009 Growth
- Australia Retail Sales Rise No Bar to Sharp Rate Cut
- Asian Stocks Tumble on Economic Woes
- Beyond Rate Cuts: Other Fed Tools Against Downturn
- Paulson's Speech on the Economy and Financial System
- Paulson: US Weighs Other Uses for the Bailout Fund
- House Democrats May Seek $500 Billion Stimulus
- Bernanke's Speech to the Austin Chamber of Commerce
It's time to look at global stocks on a top-down basis, said James Moffett, Scout Investment Advisors chairman on "Street Signs."
Moffett likes Brazilian beer company AmBev [ABV
Loading...
()
], for instance.
“We like Brazil and we like the consumer staples so they come together with a beer company,” he told CNBC's Erin Burnett. “It’s reasonably valued; the earnings are growing.”
Moffett is also bullish on Novo Nordisk AS [NVO
Loading...
()
], a healthcare company that provides insulin for diabetes patients.
“Diabetes is a worldwide epidemic and so far, they haven’t found a replacement or substitute for insulin," he said. "Novo Nordisk, it’s not a cheap stock, but it has come down relative to its growth rate and its stability."
British American Tobacco [BTI
Loading...
()
] is also an attractive buy, Moffett said.
“It’s got a four percent dividend, selling at I think twelve times earnings,” he said. “It’s a stable business; this is part of what we’re looking for on a top-down basis is stability in this type of environment."
However, Moffett cautioned investors to avoid cyclicals.
"We do see an economic recession and this is no time to try to be brave," he told CNBC's Erin Burnett. "As we come out of this then we'll get another chance to buy the more cyclical stocks."
____________________________
CNBC.com Features:
____________________________



